Skip to main content
SpringerLink
Log in

Prostatakrebs – Prävalenz, Bedeutung und Implikationen für die Prävention und Gesundheitsförderung

  • Living reference work entry
  • First Online:
Book cover Prävention und Gesundheitsförderung

Part of the book series: Springer Reference Pflege – Therapie – Gesundheit ((SRPTG))

  • 228 Accesses

Zusammenfassung

Das Prostatakarzinom (PCa) ist mit 23 % aller Krebsneuerkrankungen der häufigste maligne Tumor (außer Malignome der Haut) des Mannes und mit 11,3 % aller Krebssterbefälle auf Platz zwei der krebsbedingten Mortalität in Deutschland. Das PCa wird durch den demografischen Wandel in Deutschland an Bedeutung gewinnen, da es sich um einen Tumor des älteren Mannes handelt, mit einem Maximum der Inzidenz in der Altersgruppe der 70- bis 74-Jährigen. Außer dem Alter sind nur wenige wesentliche Risikofaktoren bekannt. Männer schwarzafrikanischen Ursprungs sind häufiger betroffen als Europäer oder weiße Nordamerikaner. Am PCa erkrankte nahe Angehörige erhöhen das Erkrankungsrisiko. Eine Keimbahnmutation im BRCA1 oder -2 Gen z. B. erhöht das Erkrankungsrisiko. Umwelt und Lebensstil könnten eine Rolle in der Krankheitsentstehung spielen, jedoch liegt hier nur wenig hochwertige Evidenz vor. Im Vergleich zur Früherkennung kommt der primären Prävention aus diesem Grund aktuell noch eine geringe Bedeutung zu.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution

Institutional subscriptions

Literatur

  • Altekruse SF, Kosary CL, Krapcho M, Neyman N, Aminou R, Waldron W, Ruhl J, Howlader N, Tatalovich Z, Cho H, Mariotto A, Eisner MP, Lewis DR, Cronin K, Chen HS, Feuer EJ, Stinchcomb DG, Edwards BK (Hrsg) (2010) SEER cancer statistics review, 1975–2007. National Cancer Institute, Bethesda. https://seer.cancer.gov/csr/1975_2007/

    Google Scholar 

  • Andriole GL, Bostwick DG, Brawley OW, Gomella LG, Marberger M, Montorsi F, Pettaway CA, Tammela TL, Teloken C, Tindall DJ, Somerville MC, Wilson TH, Fowler IL, Rittmaster RS (2010) Effect of dutasteride on the risk of prostate cancer. N Engl J Med 362:1192–1202

    Article  PubMed  CAS  Google Scholar 

  • Bonn SE, Sjolander A, Lagerros YT, Wiklund F, Stattin P, Holmberg E, Gronberg H, Balter K (2015) Physical activity and survival among men diagnosed with prostate cancer. Cancer Epidemiol Biomark Prev 24:57–64

    Article  CAS  Google Scholar 

  • Bonn SE, Barnett MJ, Thornquist M, Goodman G, Neuhouser ML (2018) Body mass index and prostate cancer risk in the Carotene and Retinol Efficacy Trial. LID – Eur J Cancer Prev 28(3):212–219. https://doi.org/10.1097/CEJ.0000000000000438

    Article  PubMed  CAS  PubMed Central  Google Scholar 

  • Bratt O, Drevin L, Akre O, Garmo H, Stattin P (2016) Family history and probability of prostate cancer, differentiated by risk category: a nationwide population-based study. J Natl Cancer Inst 108(10). https://doi.org/10.1093/jnci/djw110

    Article  PubMed  Google Scholar 

  • Breast Cancer Linkage Consortium (1999) Cancer risks in BRCA2 mutation carriers. J Natl Cancer Inst 91:1310–1316

    Article  Google Scholar 

  • Brookman-May SD, Campi R, Henriquez JDS, Klatte T, Langenhuijsen JF, Brausi M, Linares-Espinos E, Volpe A, Marszalek M, Akdogan B, Roll C, Stief CG, Rodriguez-Faba O, Minervini A (2018) Latest evidence on the impact of smoking, sports, and sexual activity as modifiable lifestyle risk factors for prostate cancer incidence, recurrence, and progression: a systematic review of the literature by the European Association of Urology Section of Oncological Urology (ESOU). Eur Urol Focus. https://doi.org/10.1016/j.euf.2018.02.007

    Article  PubMed  Google Scholar 

  • Brown JC, Winters-Stone K, Lee A, Schmitz KH (2012) Cancer, physical activity, and exercise. Compr Physiol 2:2775–2809

    PubMed  PubMed Central  Google Scholar 

  • Bunker CH, Patrick AL, Konety BR, Dhir R, Brufsky AM, Vivas CA, Becich MJ, Trump DL, Kuller LH (2002) High prevalence of screening-detected prostate cancer among Afro-Caribbeans: the Tobago Prostate Cancer Survey. Cancer Epidemiol Biomark Prev 11:726–729

    Google Scholar 

  • Castro E, Goh C, Olmos D, Saunders E, Leongamornlert D, Tymrakiewicz M, Mahmud N, Dadaev T, Govindasami K, Guy M, Sawyer E, Wilkinson R, Ardern-Jones A, Ellis S, Frost D, Peock S, Evans DG, Tischkowitz M, Cole T, Davidson R, Eccles D, Brewer C, Douglas F, Porteous ME, Donaldson A, Dorkins H, Izatt L, Cook J, Hodgson S, Kennedy MJ, Side LE, Eason J, Murray A, Antoniou AC, Easton DF, Kote-Jarai Z, Eeles R (2013) Germline BRCA mutations are associated with higher risk of nodal involvement, distant metastasis, and poor survival outcomes in prostate cancer. J Clin Oncol 31:1748–1757

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  • Gandhi J, Afridi A, Vatsia S, Joshi G, Kaplan SA, Smith NL, Khan SA (2017) The molecular biology of prostate cancer: current understanding and clinical implications. Prostate Cancer Prostatic Dis 21:22–36. https://doi.org/10.1038/s41391-017-0023-8

    Article  PubMed  Google Scholar 

  • Gansler T, Shah R, Wang Y, Stevens VL, Yang B, Newton CC, Gapstur SM, Jacobs EJ (2018) Smoking and prostate cancer-specific mortality after diagnosis in a large prospective cohort. Cancer Epidemiol Biomark Prev 27:665–672

    Article  CAS  Google Scholar 

  • Gao X, Lavalley MP, Tucker KL (2005) Prospective studies of dairy product and calcium intakes and prostate cancer risk: a meta-analysis. J Natl Cancer Inst 97:1768–1777

    Article  PubMed  CAS  Google Scholar 

  • Goldgar DE, Easton DF, Cannon-Albright LA, Skolnick MH (1994) Systematic population-based assessment of cancer risk in first-degree relatives of cancer probands. J Natl Cancer Inst 86:1600–1608

    Article  PubMed  CAS  Google Scholar 

  • Haenszel W, Kurihara M (1968) Studies of Japanese migrants. I. Mortality from cancer and other diseases among Japanese in the United States. J Natl Cancer Inst 40:43–68

    PubMed  CAS  Google Scholar 

  • Hamdy FC, Donovan JL, Lane JA, Mason M, Metcalfe C, Holding P, Davis M, Peters TJ, Turner EL, Martin RM, Oxley J, Robinson M, Staffurth J, Walsh E, Bollina P, Catto J, Doble A, Doherty A, Gillatt D, Kockelbergh R, Kynaston H, Paul A, Powell P, Prescott S, Rosario DJ, Rowe E, Neal DE (2016) 10-year outcomes after monitoring, surgery, or radiotherapy for localized prostate cancer. N Engl J Med 375:1415

    Article  PubMed  Google Scholar 

  • Imperato-Mcginley J, Gautier T, Zirinsky K, Hom T, Palomo O, Stein E, Vaughan ED, Markisz JA, Ramirez de Arellano E, Kazam E (1992) Prostate visualization studies in males homozygous and heterozygous for 5 alpha-reductase deficiency. J Clin Endocrinol Metab 75:1022–1026

    PubMed  CAS  Google Scholar 

  • Isaacs JT (1992) Hormonal balance and the risk of prostatic cancer. J Cell Biochem Suppl 16h:107–108

    Article  PubMed  CAS  Google Scholar 

  • Klein EA, Thompson IM Jr, Tangen CM, Crowley JJ, Lucia MS, Goodman PJ, Minasian LM, Ford LG, Parnes HL, Gaziano JM, Karp DD, Lieber MM, Walther PJ, Klotz L, Parsons JK, Chin JL, Darke AK, Lippman SM, Goodman GE, Meyskens FL Jr, Baker LH (2011) Vitamin E and the risk of prostate cancer: the Selenium and Vitamin E Cancer Prevention Trial (SELECT). JAMA 306:1549–1556

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  • Klotz L (2018) Prostate cancer prevention: proof is elusive. BJU Int 121:487

    Article  PubMed  Google Scholar 

  • Kotb AF, Beltagy A, Ismail AM, Hashad MM (2015) Sexual activity and the risk of prostate cancer: review article. Arch Ital Urol Androl 87:214–215

    Article  PubMed  CAS  Google Scholar 

  • Lawson KA, Wright ME, Subar A, Mouw T, Hollenbeck A, Schatzkin A, Leitzmann MF (2007) Multivitamin use and risk of prostate cancer in the National Institutes of Health-AARP Diet and Health Study. J Natl Cancer Inst 99:754–764

    Article  PubMed  CAS  Google Scholar 

  • Lin PH, Aronson W, Freedland SJ (2015) Nutrition, dietary interventions and prostate cancer: the latest evidence. BMC Med 13:3

    Article  PubMed  PubMed Central  Google Scholar 

  • Lippman SM, Klein EA, Goodman PJ, Lucia MS, Thompson IM, Ford LG, Parnes HL, Minasian LM, Gaziano JM, Hartline JA, Parsons JK, Bearden JD 3rd, Crawford ED, Goodman GE, Claudio J, Winquist E, Cook ED, Karp DD, Walther P, Lieber MM, Kristal AR, Darke AK, Arnold KB, Ganz PA, Santella RM, Albanes D, Taylor PR, Probstfield JL, Jagpal TJ, Crowley JJ, Meyskens FL Jr, Baker LH, Coltman CA Jr (2009) Effect of selenium and vitamin E on risk of prostate cancer and other cancers: the Selenium and Vitamin E Cancer Prevention Trial (SELECT). JAMA 301:39–51

    Article  PubMed  CAS  Google Scholar 

  • Mitra A, Fisher C, Foster CS, Jameson C, Barbachanno Y, Bartlett J, Bancroft E, Doherty R, Kote-Jarai Z, Peock S, Easton D, Eeles R (2008) Prostate cancer in male BRCA1 and BRCA2 mutation carriers has a more aggressive phenotype. Br J Cancer 98:502–507

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  • Powe CE, Evans MK, Wenger J, Zonderman AB, Berg AH, Nalls M, Tamez H, Zhang D, Bhan I, Karumanchi SA, Powe NR, Thadhani R (2013) Vitamin D-binding protein and vitamin D status of black Americans and white Americans. N Engl J Med 369:1991–2000

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  • RKI Robert Koch-Institut 2013/2014 DEUTSCHLAND, R. K. I. U. D. G. D. E. K. I. Krebs in Deutschland für 2013/2014

    Google Scholar 

  • Scheideler JK, Klein WMP (2018) Awareness of the link between alcohol consumption and cancer across the world: a review. Cancer Epidemiol Biomark Prev 27:429–437

    Article  Google Scholar 

  • Shimizu H, Ross RK, Bernstein L, Yatani R, Henderson BE, Mack TM (1991) Cancers of the prostate and breast among Japanese and white immigrants in Los Angeles County. Br J Cancer 63:963–966

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  • Thompson D, Easton D (2001) Variation in cancer risks, by mutation position, in BRCA2 mutation carriers. Am J Hum Genet 68:410–419

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  • Thompson IM, Goodman PJ, Tangen CM, Lucia MS, Miller GJ, Ford LG, Lieber MM, Cespedes RD, Atkins JN, Lippman SM, Carlin SM, Ryan A, Szczepanek CM, Crowley JJ, Coltman CA Jr (2003) The influence of finasteride on the development of prostate cancer. N Engl J Med 349:215–224

    Article  PubMed  CAS  Google Scholar 

  • Trump DL, Aragon-Ching JB (2018) Vitamin D in prostate cancer. Asian J Androl 20:244–252

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  • Urquiza-Salvat N, Pascual-Geler M, Lopez-Guarnido O, Rodrigo L, Martinez-Burgos A, Cozar JM, Ocana-Peinado FMA, Alvarez-Cubero MJ, Rivas A (2018) Adherence to Mediterranean diet and risk of prostate cancer

    Google Scholar 

  • Vartolomei MD, Kimura S, Ferro M, Foerster B, Abufaraj M, Briganti A, Karakiewicz PI, Shariat SF (2018) The impact of moderate wine consumption on the risk of developing prostate cancer. Clin Epidemiol 10:431–444

    Article  PubMed  PubMed Central  Google Scholar 

  • Wekesa A, Harrison M, Watson RW (2015) Physical activity and its mechanistic effects on prostate cancer. Prostate Cancer Prostatic Dis 18:197–207

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Klinik für Urologie, Uro-Onkologie, spezielle urologische und Roboter-assistierte Chirurgie, Universitätsklinik Köln, Köln, Deutschland

    Tobias Kohl & Markus Grabbert

  2. Klinik für Urologie, Uro-Onkologie, spezielle urologische und Roboter-assistierte Chirurgie, Universitätsklinikum Köln, Köln, Deutschland

    Axel Heidenreich

Authors
  1. Tobias Kohl
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Markus Grabbert
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Axel Heidenreich
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Tobias Kohl .

Editor information

Editors and Affiliations

  1. Dortmund, Germany

    Michael Tiemann

  2. Leichlingen, Germany

    Melvin Mohokum

Rights and permissions

Reprints and permissions

Copyright information

© 2019 Springer-Verlag GmbH Deutschland, ein Teil von Springer Nature

About this entry

Check for updates. Verify currency and authenticity via CrossMark

Cite this entry

Kohl, T., Grabbert, M., Heidenreich, A. (2019). Prostatakrebs – Prävalenz, Bedeutung und Implikationen für die Prävention und Gesundheitsförderung. In: Tiemann, M., Mohokum, M. (eds) Prävention und Gesundheitsförderung. Springer Reference Pflege – Therapie – Gesundheit . Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-662-55793-8_48-1

Download citation

  • DOI: https://doi.org/10.1007/978-3-662-55793-8_48-1

  • Received:

  • Accepted:

  • Published:

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-662-55793-8

  • Online ISBN: 978-3-662-55793-8

  • eBook Packages: Springer Referenz Medizin

Publish with us

Policies and ethics

Search

Navigation